Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Kolesnichenko LS et al
While no studies have specifically examined this in tirzepatide users, the biological plausibility is sound
Retatrutide is a more recently developed investigational compound a triple agonist targeting the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors simultaneously
Most data comes from individual peptide research, and human clinical trials for the combination are completely absent from peer-reviewed literature
All content is intended for in vitro laboratory research purposes only
To optimize absorption and minimize local irritation, it is recommended to rotate injection sites, such as the upper arms, thighs, and areas around the navel
